Skip Navigation

Laboratory of Host Defenses

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Harry L. Malech, M.D., Chief

301-480-6916
hmalech@niaid.nih.gov

The Laboratory of Host Defenses (LHD) studies the immune functions essential for host defense against infection. LHD also studies the genetics and pathophysiology of inherited primary immune deficiencies. These abnormalities may be associated with recurrent infections and/or dysfunctions of immune homeostasis, which the lab investigates in clinical protocols.

LHD clinical investigations aim to develop new diagnostic and therapeutic approaches to the management or correction of immune dysfunction in patients.

  • Research Objectives

  • Discovery of the gene mutations causing primary immune deficiencies and autoimmune disorders
  • Detection and treatment of associated infections
  • Determination of the basis for excessive inflammation and associated autoimmune symptoms
  • Use of cytokines, monoclonal antibodies, gene transfer technologies, and other therapeutics to modify or correct immune function, prevent infection, and reduce inflammation
  • Application of gene therapy and allogeneic or autologous stem cell and immune cell transplantation for correction of disorders of immune function

Sections and Units

Clinical Immunology Unit

Ashish Jain, M.D.

Clinical Pathophysiology Section

John I. Gallin, M.D.
Douglas Kuhns, Ph.D.
Kol Zarember, Ph.D.

Genetic Immunotherapy Section

Harry L. Malech, M.D.
Elizabeth M. Kang, M.D.
Suk See De Ravin, M.D., Ph.D.
Uimook Choi, Ph.D.

Human Immunological Diseases Unit

Helen C. Su, M.D., Ph.D.

Molecular Defenses Section

Thomas L. Leto, Ph.D.
Jaeyul Kwon, Ph.D.

Monocyte Trafficking Unit

Sharon H. Jackson, M.D.

Mucosal Immunity Section

Warren Strober, M.D.
Ivan J. Fuss, M.D. 
Atsushi Kitani, M.D., Ph.D.
Michael D. Yao, M.D.

Last Updated July 09, 2008